← TEVA PHARMACEUTICAL INDUSTRIES LTD TEVA
Market Price
$36.77
Market Cap
$42.48B
P/E Ratio
30.39
Revenue (FY 2025)
↑4.3% YoY
$17.26B
3-Yr CAGR: 5.0%
Net Income
↑186.0% YoY
$1.41B
Net Margin: 8.2%
Free Cash Flow
↑53.3% YoY
$1.15B
FCF Yield: 2.70%
EPS (Diluted)
↑183.4% YoY
$1.21
Basic: $1.23
Return on Equity
Efficiency
17.8%
ROA: 10.1%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (TEVA)
All monetary values in millions ($M)| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2016 | $21,903.0M | — | $11,859.0M | $68.0M | — | $0.07 | — | $5,225.0M | $4,324.0M | — |
| FY 2017 | $22,385.0M | +2.2% | $10,615.0M | $-16,265.0M | -24,019.1% | $-16.26 | -23,328.6% | $2,225.0M | $1,351.0M | -68.8% |
| FY 2018 | $18,854.0M | -15.8% | $8,296.0M | $-2,150.0M | +86.8% | $-2.35 | +85.5% | $2,446.0M | $1,795.0M | +32.9% |
| FY 2019 | $16,887.0M | -10.4% | $7,537.0M | $-999.0M | +53.5% | $-0.91 | +61.3% | $748.0M | $223.0M | -87.6% |
| FY 2020 | $16,659.0M | -1.4% | $7,726.0M | $-3,990.0M | -299.4% | $-3.64 | -300.0% | $1,216.0M | $638.0M | +186.1% |
| FY 2021 | $15,878.0M | -4.7% | $7,594.0M | $417.0M | +110.5% | $0.38 | +110.4% | $798.0M | $236.0M | -63.0% |
| FY 2022 | $14,925.0M | -6.0% | $6,973.0M | $-2,353.0M | -664.3% | $-2.12 | -657.9% | $1,590.0M | $1,042.0M | +341.5% |
| FY 2023 | $15,846.0M | +6.2% | $7,645.0M | $-559.0M | +76.2% | $-0.50 | +76.4% | $1,368.0M | $842.0M | -19.2% |
| FY 2024 | $16,544.0M | +4.4% | $8,064.0M | $-1,639.0M | -193.2% | $-1.45 | -190.0% | $1,247.0M | $749.0M | -11.0% |
| FY 2025 | $17,258.0M | +4.3% | $8,938.0M | $1,410.0M | +186.0% | $1.21 | +183.4% | $1,649.0M | $1,148.0M | +53.3% |
Valuation
Market Price
$36.77
Market Cap
$42.48B
Enterprise Value
N/A
P/E Ratio
30.39
P/B Ratio
5.41
FCF Yield
2.70%
Dividend Yield
0.00%
Shares Outstanding
Profitability & Margins
Gross Margin
51.79%
Operating Margin
12.50%
Net Margin
8.17%
Return on Equity (ROE)
17.83%
Return on Assets (ROA)
10.11%
Asset Turnover
1.24x
Revenue 3-Yr CAGR
4.96%
Financial Health & Liquidity
Current Ratio
1.04
Cash Ratio
0.26
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$3.56B
Total Debt
N/A
Book Value / Share
$6.79
Cash Flow Efficiency
Operating Cash Flow
$1.65B
Capital Expenditures (CapEx)
$501.00M
Free Cash Flow
$1.15B
OCF / Revenue
9.55%
FCF / Revenue
6.65%
FCF 3-Yr CAGR
3.28%
Per Share Metrics
EPS (Diluted)
$1.21
EPS (Basic)
$1.23
Dividends / Share
N/A
Book Value / Share
$6.79
EPS YoY Growth
183.45%
Balance Sheet (FY 2025)
Total Assets
$13.95B
Total Liabilities
$13.46B
Stockholders' Equity
$7.91B
Current Assets
$13.95B
Current Liabilities
$13.46B